Filtros de búsqueda

Lista de obras de Frede Donskov

A five-factor biomarker profile obtained week 4-12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2.

artículo científico publicado en 2015

A population-based overview of sequences of targeted therapy in metastatic renal cell carcinoma.

artículo científico publicado en 2013

A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC): results from the Danish Renal Cancer Group (DaRenCa) study-1.

artículo científico publicado en 2018

Active Smoking Is Associated With Worse Prognosis in Metastatic Renal Cell Carcinoma Patients Treated With Targeted Therapies

artículo científico publicado en 2018

Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results.

artículo científico publicado en 2017

Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy

artículo científico publicado en 2016

Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial

scientific article published on 01 October 2018

Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial

scientific article published on 09 May 2019

Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial.

artículo científico publicado en 2016

Carbon anhydrase IX specific immune responses in patients with metastatic renal cell carcinoma potentially cured by interleukin-2 based immunotherapy.

artículo científico publicado en 2013

Carcinoma of Unknown Primary Site (CUP) With Metastatic Renal-Cell Carcinoma (mRCC) Histologic and Immunohistochemical Characteristics (CUP-mRCC): Results From Consecutive Patients Treated With Targeted Therapy and Review of Literature

scientific article published on 28 August 2018

Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy.

artículo científico publicado en 2016

Characteristics of long-term and short-term survivors of metastatic renal cell carcinoma treated with targeted therapies: results from the International mRCC Database Consortium

artículo científico publicado en 2014

Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies.

artículo científico publicado en 2014

Characterizing the outcomes of metastatic papillary renal cell carcinoma

artículo científico publicado en 2017

CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma

artículo científico publicado en 2017

Clinical Outcomes of First-line Sunitinib Followed by Immuno-oncology Checkpoint Inhibitors in Patients With Metastatic Renal Cell Carcinoma

artículo científico publicado en 2019

Combination of zoledronic Acid and targeted therapy is active but may induce osteonecrosis of the jaw in patients with metastatic renal cell carcinoma

artículo científico publicado en 2013

Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study.

artículo científico publicado en 2012

Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

scientific article published on 05 April 2019

Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.

artículo científico publicado en 2014

Diagnosis of hyponatremia and increased risk of a subsequent cancer diagnosis: results from a nationwide population-based cohort study

artículo científico publicado en 2017

Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma.

artículo científico publicado en 2017

Dynamic Contrast-Enhanced Computed Tomography-Derived Blood Volume and Blood Flow Correlate With Patient Outcome in Metastatic Renal Cell Carcinoma

artículo científico publicado en 2017

Dynamic contrast-enhanced computed tomography as a potential biomarker in patients with metastatic renal cell carcinoma: preliminary results from the Danish Renal Cancer Group Study-1.

artículo científico publicado en 2014

Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-Line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma

artículo científico publicado en 2020

Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category

artículo científico publicado en 2016

Efficacy of targeted therapy for metastatic renal cell carcinoma in the elderly patient population.

artículo científico publicado en 2014

Elevated neutrophil-lymphocyte ratio combined with hyponatremia indicate poor prognosis in renal cell carcinoma

scientific article published on 26 August 2019

Everolimus-induced pneumonitis associates with favourable outcome in patients with metastatic renal cell carcinoma.

artículo científico publicado en 2017

Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue

scientific article published on 01 January 1996

External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study

artículo científico publicado en 2013

Fas Ligand Expression in Metastatic Renal Cell Carcinoma During Interleukin-2 Based Immunotherapy: No In vivo Effect of Fas Ligand Tumor Counterattack

artículo científico publicado en 2004

Favorable prognostic impact of Natural Killer cells and T cells in high-grade serous ovarian carcinoma

scientific article published on 14 January 2020

First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC.

artículo científico publicado en 2014

First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium

artículo científico publicado en 2019

First-line Mammalian target of rapamycin inhibition in metastatic renal cell carcinoma: an analysis of practice patterns from the International Metastatic Renal Cell Carcinoma Database Consortium

artículo científico publicado en 2014

First-line sunitinib versus pazopanib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.

artículo científico publicado en 2016

Folic Acid Reduces Mucositis in Metastatic Renal Cell Carcinoma Patients: A Retrospective Study

scientific article published on 06 April 2019

Health economic changes as a result of implementation of targeted therapy for metastatic renal cell carcinoma: national results from DARENCA study 2.

artículo científico publicado en 2014

Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma.

artículo científico publicado en 2010

Hyponatremia associates with poor outcome in metastatic renal cell carcinoma patients treated with everolimus: prognostic impact

artículo científico publicado en 2018

Immune response in blood and tumour tissue in patients with metastatic malignant melanoma treated with IL-2, IFN alpha and histamine dihydrochloride.

artículo científico publicado en 2003

Immunohistochemical expression of carbonic anhydrase IX assessed over time and during treatment in renal cell carcinoma

artículo científico publicado en 2008

Immunomonitoring and prognostic relevance of neutrophils in clinical trials.

artículo científico publicado en 2013

Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer patients: Assessment of chemotherapy for resolution of unfavourable neutrophilia.

artículo científico publicado en 2013

Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy

artículo científico publicado en 2013

Impact of immune parameters on long-term survival in metastatic renal cell carcinoma

artículo científico publicado en 2006

Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: results from the Danish Renal Cancer Group (DARENCA) study-2.

artículo científico publicado en 2013

Increased intratumoral FOXP3-positive regulatory immune cells during interleukin-2 treatment in metastatic renal cell carcinoma

artículo científico publicado en 2009

Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma.

artículo científico publicado en 2011

Leukocyte orchestration in blood and tumour tissue following interleukin-2 based immunotherapy in metastatic renal cell carcinoma.

artículo científico publicado en 2004

Living with Advanced Kidney Cancer and Treatment with Cabozantinib: Through the Eyes of the Patient and the Physician

scientific article published on 22 March 2018

Monocytes and neutrophils as 'bad guys' for the outcome of interleukin-2 with and without histamine in metastatic renal cell carcinoma--results from a randomised phase II trial

artículo científico publicado en 2006

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.

artículo científico publicado en 2018

Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial

scientific article published on 16 August 2019

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

artículo científico publicado en 2015

On-treatment biomarkers in metastatic renal cell carcinoma: towards individualization of prognosis?

artículo científico publicado en 2016

Outcome of patients with metastatic sarcomatoid renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.

artículo científico publicado en 2014

Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma

scientific article published on 27 December 2019

Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials.

artículo científico publicado en 2014

Outpatient treatment with subcutaneous histamine dihydrochloride in combination with interleukin-2 and interferon-alpha in patients with metastatic renal cell carcinoma: results of an open single-armed multicentre phase II study

artículo científico publicado en 2002

Pazopanib Exposure Relationship with Clinical Efficacy and Safety in the Adjuvant Treatment of Advanced Renal Cell Carcinoma.

artículo científico publicado en 2018

Pazopanib-Induced Liver Toxicity in Patients With Metastatic Renal Cell Carcinoma: Effect of UGT1A1 Polymorphism on Pazopanib Dose Reduction, Safety, and Patient Outcomes

artículo científico publicado en 2019

Phase III Trial of Adjuvant Sunitinib in Patients With High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis

artículo científico publicado en 2018

Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma

artículo científico publicado en 2009

Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapy

artículo científico publicado en 2011

Progression-free survival as a predictor of overall survival in metastatic renal cell carcinoma treated with contemporary targeted therapy.

artículo científico publicado en 2010

Quality of Life Outcomes for Cabozantinib Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma: METEOR Phase III Randomized Trial.

artículo científico publicado en 2018

Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma.

artículo científico publicado en 2017

Real-World Assessment of Clinical Outcomes Among First-Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group

scientific article published on 23 January 2020

Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium

artículo científico publicado en 2019

Registrations of Patients with Renal Cell Carcinoma in the Nationwide Danish Renal Cancer Database versus the Danish Cancer Registry: Data Quality, Completeness and Survival (DaRenCa Study-3)

scientific article published on 27 July 2020

Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients

artículo científico publicado en 2015

Sunitinib-induced hypertension, neutropaenia and thrombocytopaenia as predictors of good prognosis in patients with metastatic renal cell carcinoma

artículo científico publicado en 2014

Survival outcome and treatment response of patients with late relapse from renal cell carcinoma in the era of targeted therapy.

artículo científico publicado en 2013

Synchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome-Results from the International Metastatic Renal Cell Carcinoma Database Consortium

artículo científico publicado en 2020

The Advent of Psycho-oncology in Metastatic Renal Cell Carcinoma

artículo científico publicado en 2016

The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study

artículo científico publicado en 2015

The database of the Danish Renal Cancer Group

artículo científico publicado en 2016

The impact of low serum sodium on treatment outcome of targeted therapy in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Cancer Database Consortium

artículo científico publicado en 2013

Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.

artículo científico publicado en 2016

Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in CheckMate 025.

artículo científico

Tumor-associated neutrophils and macrophages in non-small cell lung cancer: no immediate impact on patient outcome.

artículo científico publicado en 2013

Tumor-associated neutrophils as a new prognostic factor in cancer: a systematic review and meta-analysis

artículo científico publicado en 2014

Tumour-associated CD66b+ neutrophil count is an independent prognostic factor for recurrence in localised cervical cancer

artículo científico publicado en 2013

Use of patient outcome endpoints to identify the best functional CT imaging parameters in metastatic renal cell carcinoma patients.

artículo científico publicado en 2017

[Medical work when cancer is organized as an acute disease. New South Wales, Australia, an example]

artículo científico publicado en 2007

[Nephrectomy in metastatic renal cell carcinoma--an old myth in new clothes?]

scientific article published on 01 February 2003

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda